All Stories

  1. Stillbirth rates, service outcomes and costs of implementing NHS England’s Saving Babies’ Lives care bundle in maternity units in England: A cohort study
  2. A missense mutation of ErbB2 produces a novel mouse model of stillbirth associated with a cardiac abnormality but lacking abnormalities of placental structure
  3. Increased placental macrophages and a pro‐inflammatory profile in placentas and maternal serum in infants with a decreased growth rate in the third trimester of pregnancy
  4. Assessment of the quality, content and perceived utility of local maternity guidelines in hospitals in England implementing the saving babies’ lives care bundle to reduce stillbirth
  5. Evaluating improvement interventions using routine data to support a learning health system: research design, data access, analysis and reporting
  6. Intra‐placental arterial Doppler: A marker of fetoplacental vascularity in late‐onset placental disease?
  7. Need to ensure that improvements in stillbirth rates are also achieved in high‐risk groups
  8. Evaluating the accuracy and precision of sonographic fetal weight estimation models in extremely early‐onset fetal growth restriction
  9. The effect of high glucose on lipid metabolism in the human placenta
  10. The kynurenine pathway; A new target for treating maternal features of preeclampsia?
  11. Research priorities and potential methodologies to inform care in subsequent pregnancies following stillbirth: a web-based survey of healthcare professionals, researchers and advocates
  12. ‘Real experiences which increase empathy’ – a preliminary exploration of the utility of an audio archive describing parents’ and clinicians’ experiences of stillbirth
  13. PARENTS 2 Study: a qualitative study of the views of healthcare professionals and stakeholders on parental engagement in the perinatal mortality review—from ‘bottom of the pile’ to joint learning
  14. Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced f...
  15. A mixed-methods evaluation of continuous electronic fetal monitoring for an extended period
  16. Alterations in maternally perceived fetal movement and their association with late stillbirth: findings from the Midland and North of England stillbirth case–control study
  17. “They told me all mothers have worries”, stillborn mother's experiences of having a ‘gut instinct’ that something is wrong in pregnancy: Findings from an international case–control study
  18. The Collaborative IPD of Sleep and Stillbirth (Cribss): is maternal going-to-sleep position a risk factor for late stillbirth and does maternal sleep position interact with fetal vulnerability? An individual participant data meta-analysis study protocol
  19. Saving babies’ lives project impact and results evaluation (SPiRE): a mixed methodology study
  20. Care of pregnant women with decreased fetal movements: Update of a clinical practice guideline for Australia and New Zealand
  21. Understanding the associations and significance of fetal movements in overweight or obese pregnant women: a systematic review
  22. Women's experiences of continuous fetal monitoring - a mixed-methods systematic review
  23. Stillbirth is associated with perceived alterations in fetal activity – findings from an international case control study
  24. Can promoting awareness of fetal movements and focusing interventions reduce fetal mortality? A stepped-wedge cluster randomised trial (AFFIRM)
  25. Assessing the quality of bereavement care after perinatal death: development and piloting of a questionnaire to assess parents’ experiences
  26. Use of biochemical tests of placental function for improving pregnancy outcome
  27. Professionals' views of fetal-monitoring support the development of devices to provide objective longer-term assessment of fetal wellbeing
  28. Placental Features of Late-Onset Adverse Pregnancy Outcome
  29. Protecting families from recurrent stillbirth
  30. Antiphospholipid Antibodies Alter Cell-Death-Regulating Lipid Metabolites in First and Third Trimester Human Placentae
  31. IFPA meeting 2014 workshop report: Animal models to study pregnancy pathologies; new approaches to study human placental exposure to xenobiotics; biomarkers of pregnancy pathologies; placental genetics and epigenetics; the placenta and stillbirth and f...
  32. IFPA Gábor Than Award Lecture: Recognition of placental failure is key to saving babies' lives
  33. Evaluation of the quality of guidelines for the management of reduced fetal movements in UK maternity units
  34. Continuous objective recording of fetal heart rate and fetal movements could reliably identify fetal compromise, which could reduce stillbirth rates by facilitating timely management
  35. Systematic review of placental pathology reported in association with stillbirth
  36. Circulating Cytokines and Alarmins Associated with Placental Inflammation in High-Risk Pregnancies
  37. A stochastic model for early placental development
  38. The Midland and North of England Stillbirth Study (MiNESS)
  39. UNDERSTANDING THE PLACENTAL AETIOLOGY OF FETAL GROWTH RESTRICTION; COULD THIS LEAD TO PERSONALIZED MANAGEMENT STRATEGIES?
  40. Parents’ experiences and expectations of care in pregnancy after stillbirth or neonatal death: a metasynthesis
  41. Preeclampsia Is Associated with Alterations in the p53-Pathway in Villous Trophoblast
  42. Analysis of syncytial nuclear aggregates in preeclampsia shows increased sectioning artefacts and decreased inter-villous bridges compared to healthy placentas
  43. A structured review and exploration of the healthcare costs associated with stillbirth and a subsequent pregnancy in England and Wales
  44. MANAGEMENT OF REDUCED FETAL MOVEMENTS
  45. Duration and method of tissue storage alters placental morphology – Implications for clinical and research practice
  46. Investigating the association of villitis of unknown etiology with stillbirth and fetal growth restriction – A systematic review
  47. Peripartum and intrapartum assessment of the fetus
  48. Syncytial nuclear aggregates in normal placenta show increased nuclear condensation, but apoptosis and cytoskeletal redistribution are uncommon
  49. A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation-a feasibility study
  50. Interventions for supporting parents’ decisions about autopsy after stillbirth
  51. Bereaved parents’ experience of stillbirth in UK hospitals: a qualitative interview study
  52. Sharing experiences to improve bereavement support and clinical care after stillbirth: report of the 7th annual meeting of the international stillbirth alliance
  53. Identification of autophagic vacuoles and regulators of autophagy in villous trophoblast from normal term pregnancies and in fetal growth restriction
  54. A high-throughput colorimetric-assay for monitoring glucose consumption by cultured trophoblast cells and placental tissue
  55. Correlation between abnormal placental appearance at routine 2nd trimester ultrasound scan and histological examination of the placenta after birth
  56. Abnormalities of the placenta
  57. Reduced fetal movements
  58. Predictors of Poor Perinatal Outcome following Maternal Perception of Reduced Fetal Movements – A Prospective Cohort Study
  59. Placental expression of anti-angiogenic proteins in mirror syndrome: A case report
  60. A difficult conversation? The views and experiences of parents and professionals on the consent process for perinatal postmortem after stillbirth
  61. Post-mortem examination after stillbirth: views of UK-based practitioners
  62. A Metabolomic Approach Identifies Differences in Maternal Serum in Third Trimester Pregnancies That End in Poor Perinatal Outcome
  63. Maternal Perception of Reduced Fetal Movements Is Associated with Altered Placental Structure and Function
  64. Maternal perception of altered fetal activity and the risk of late stillbirth
  65. IFPA Meeting 2011 workshop report I: Placenta: Predicting future health; roles of lipids in the growth and development of feto-placental unit; placental nutrient sensing; placental research to solve clinical problems – A translational approach
  66. IFPA Meeting 2011 workshop report III: Placental immunology; epigenetic and microRNA-dependent gene regulation; comparative placentation; trophoblast differentiation; stem cells
  67. Do medical certificates of stillbirth provide accurate and useful information regarding the cause of death?
  68. Erratum to “Abstracts for the IFPA Meeting 2011” [Placenta 32 (2011) A1–A149]
  69. A case of confined placental mosaicism with double trisomy associated with stillbirth
  70. The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy
  71. Fetal blood sampling in early labour: is there an increased risk of operative delivery and fetal morbidity?
  72. Review: The effects of oxygen on normal and pre-eclamptic placental tissue – insights from metabolomics
  73. Bladder perforation: A rare complication during diagnostic hysteroscopy
  74. Identifying placental dysfunction in women with reduced fetal movements can be used to predict patients at increased risk of pregnancy complications
  75. Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast
  76. Towards an end to stillbirths
  77. Changes in the Metabolic Footprint of Placental Explant-Conditioned Medium Cultured in Different Oxygen Tensions from Placentas of Small for Gestational Age and Normal Pregnancies
  78. Placental Apoptosis in Health and Disease
  79. Auscultation of the fetal heart in early pregnancy
  80. Concurrent maternal and fetal ovarian cysts
  81. The use of the birthing pool after a diagnosis of stillbirth
  82. Changes in the Metabolic Footprint of Placental Explant-Conditioned Culture Medium Identifies Metabolic Disturbances Related to Hypoxia and Pre-Eclampsia
  83. Detection and management of decreased fetal movements in Australia and New Zealand: A survey of obstetric practice
  84. A Case of Intrauterine Growth Restriction in Association with Placental Mesenchymal Dysplasia with Abnormal Placental Lymphatic Development
  85. Can post-mortem examination of the placenta help determine the cause of stillbirth?
  86. Elevated bile acids associated with acute hepatitis A infection in the third trimester of pregnancy
  87. Predicting poor perinatal outcome in women who present with decreased fetal movements
  88. Altered Expression of Regulators of Caspase Activity within Trophoblast of Normal Pregnancies and Pregnancies Complicated by Preeclampsia
  89. Live and Let Die – Regulation of Villous Trophoblast Apoptosis in Normal and Abnormal Pregnancies
  90. Analysis of the Metabolic Footprint and Tissue Metabolome of Placental Villous Explants Cultured at Different Oxygen Tensions Reveals Novel Redox Biomarkers
  91. Fetal Movement Assessment
  92. Management of Decreased Fetal Movements
  93. Midwives’ and Obstetricians’ Knowledge and Management of Women Presenting With Decreased Fetal Movements
  94. Effects of Oxygen on Cell Turnover and Expression of Regulators of Apoptosis in Human Placental Trophoblast☆
  95. Methods of fetal movement counting and the detection of fetal compromise
  96. Erratum to “Formation of Syncytial Knots is Increased by Hyperoxia, Hypoxia and Reactive Oxygen Species” [Placenta 28, Supplement A, Trophoblast Research, Volume 21 (2007) S33–S40]
  97. Epidermal growth factor rescues trophoblast apoptosis induced by reactive oxygen species
  98. The Mitotic Manipulation of Cytotrophoblast Differentiation In Vitro
  99. Formation of Syncytial Knots is Increased by Hyperoxia, Hypoxia and Reactive Oxygen Species
  100. Oxidative Stress and Pregnancy Outcome: A Workshop Report
  101. OBSTETRIC MANAGEMENT OF TEENAGE PREGNANCY
  102. Placental cell turnover in health and disease
  103. Acupressure for the in-patient treatment of nausea and vomiting in early pregnancy: A randomized control trial
  104. A case of isolated peripartum elevation of alkaline phosphatase in pregnancy complicated by gestational diabetes
  105. Is regional anaesthesia better than general anaesthesia for caesarean section?
  106. A case of gestational diabetes arising following treatment with glucocorticosteroids for pemphigoid gestationis
  107. What investigation is appropriate following maternal perception of reduced fetal movements?
  108. The teaching and use of a mnemonic to improve the management of shoulder dystocia
  109. An unusual cause of urinary retention in early pregnancy
  110. A case of fetal pericardial effusion in association with maternal hypertension and HIV infection
  111. A retrospective study to determine if umbilical cord pH correlates with duration of delay between delivery of the head and body in shoulder dystocia
  112. Vasculitic lesion involving the uterine cervix in a patient with anti-nuclear antibodies